CLICK HERE to access the online submission system
2025 SID Abstract Categories/Definitions:
Adaptive and Auto-Immunity
Studies of adaptive immune responses involving T and B lymphocytes, dendritic cells, other antigen presenting cells, and antigen processing and presentation; Basic and pre-clinical experimental studies focused on autoimmunity.
Bioinformatics, Computational Biology, and Imaging
Bioinformatic analyses and approaches to study skin mechanisms through single-cell and spatial-sequencing, and other AI, imaging and -omic technologies.
Cell Communication Networks and Stromal Biology
Studies on cell interactions which may include cell-cell interactions, cellular messengers, cell-matrix interactions, and cell-stromal interactions. Included but is not limited to cellular interactions between keratinocytes, nerves (neuro-cutaneous biology), melanocytes, fibroblasts, adipocytes, endothelial and immune cells and progenitors in skin; includes their local cellular and extracellular environments that affect skin inflammation, sensation (e.g., itch and pain), signaling, adhesion, migration, development and homeostasis.
Clinical Research – Epidemiology and Observational Research
Epidemiological studies of populations or patient cohorts that evaluate, but are not limited to, the natural history of disease, disease burden, co-morbidities. Socio-behavioral studies, including but not limited to, studies of patient and/or provider behaviors and attitudes towards diseases, treatments, diagnostic and screening tests, and health care delivery. Health services research studies including, but not limited to, studies of access, use, delivery, quality, and cost-effectiveness of dermatologic care, health-related quality of life, and patient-reported outcomes research. (Abstracts evaluating or comparing therapies, devices, or other interventions for the treatment of skin diseases should be submitted under “Clinical Research – Interventional Research.” Abstracts on melanoma-related clinical studies should be submitted under “Pigmentation, Melanoma, and Melanoma Immune Surveillance.”)
Clinical Research – Interventional Research
Clinical studies in humans that evaluate or compare therapies, devices, or other interventions for the treatment of skin diseases. This may include systematic reviews and/or meta-analyses of interventional studies. (Abstracts on melanoma-related clinical studies should be submitted under “Pigmentation, Melanoma, and Melanoma Immune Surveillance.”)
Epidermal Structure and Barrier Function
Research on the components or regulation of keratinocyte proliferation, differentiation, including epidermal barrier maintenance and function.
Genetic Disease, Gene Regulation, Gene Therapy & Epigenetics
Studies on epigenetics, cutaneous gene expression (including genomic based studies) and genetic diseases including gene therapy (Cancer-related genetic studies are more appropriate for UV Biology/Injury, Carcinogenesis and Cancer Genetics).
Innate Immunity, Microbiology, and Microbiome
Studies of cells, receptors and effector molecules of the innate immune response; studies on skin microbes, microbiome and infectious processes of the skin.
Minoritized Populations and Health Disparities Research
Studies of health disparities or the pathogenesis or treatment of skin diseases that disproportionately affect individuals from or are more severe among minoritized populations.
Pigmentation, Melanoma, and Melanoma Immune Surveillance
Studies on all aspects of cutaneous and extracutaneous pigmentation. This includes genetics of melanoma and pigmentary disorders; molecular, cellular, and biological facets of melanoma, melanoma progression, and immune surveillance and treatment.
Stem Cell Biology, Tissue Regeneration and Wound Healing
Wound healing and regeneration studies; vascular biology including processes/signaling that regulate vascular development and angiogenesis; interactions between different skin components that contribute to the functional process of wound healing or tissue regeneration, or abnormal wound healing (keloids/fibrosis)
Translational Studies: Cell and Molecular Biology
In vitro and ex vivo studies to interrogate drug candidates in disease pathogenesis, inflammatory signaling, and biomarker identification
Translational Studies: Preclinical
In vivo studies investigating/characterizing the mechanism of action and clinically relevant biomarkers for drug candidates
UV Biology/Injury and Non-Melanoma Cancers
Studies on UV associated damage/repair, radiation exposure, and non-melanoma cancers. This includes studies focused on disease pathogenesis, including genetics, molecular, cellular, and biological facets. (Abstracts on mechanisms of melanoma development should be submitted under “Pigmentation, Melanoma, and Melanoma Immune Surveillance.”)